Publication

N=; Drug

Trial Name

LRTI among CCR5 antagonist

LRTI Control arm

LRTI

Cooper JID [16]

721; maraviroc

MERIT: Maraviroc in treatment Naïve

2 Lobar Pneumonia; 1PCP

0

Saag JID [17]

186(OBT versus OD and BID maraviroc

Maraviroc in treatment experienced

5 Bronchitis;PCP 4

0 bronchitis PCP-0 Pneumonia-1

Gulick NEJM [18]

1049; maraviroc

MOTIVATE 1+2: (601+474) PLACEBO-209

2 PCP; Pneumonia 4

URTI 16+20 (PLACEBO=1)

11 LRTI; 7 PCP

1 LRTI; 0 PCP

Table 1: Maraviroc large RCT’s- comparison of respiratory infections among treatment and control arms.